The vast majority of individuals labelled as allergic are not deemed truly allergic upon appropriate assessment by an allergist. A label of beta-lactam allergy carries important risks for individual and public health. This article provides an overview of beta-lactam allergy, implications of erroneous beta-lactam allergy labels and the impact that can be provided by structured allergy assessment. We provide recommendations on how to stratify risk of beta-lactam allergy, beta lactam challenge protocols as well as management of patients at high risk of beta-lactam allergy.
CITATION STYLE
Jeimy, S., Ben-Shoshan, M., Abrams, E. M., Ellis, A. K., Connors, L., & Wong, T. (2020, December 1). Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology. Allergy, Asthma and Clinical Immunology. BioMed Central Ltd. https://doi.org/10.1186/s13223-020-00494-2
Mendeley helps you to discover research relevant for your work.